Biomerica Company Profile (OTCMKTS:BMRA)

About Biomerica (OTCMKTS:BMRA)

Biomerica logoBiomerica, Inc. is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The Company operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The Company's diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations. The Company primarily focuses on products for gastrointestinal (GI), food intolerances, diabetes and esoteric tests. The Company's diagnostic products use immunoassay technology.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:BMRA
  • CUSIP: N/A
  • Web: www.biomerica.com/
Capitalization:
  • Market Cap: $22.86 million
  • Outstanding Shares: 8,508,000
Average Prices:
  • 50 Day Moving Avg: $2.57
  • 200 Day Moving Avg: $2.44
  • 52 Week Range: $1.53 - $3.38
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -15.80
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $5.67 million
  • Price / Sales: 4.03
  • Book Value: $0.57 per share
  • Price / Book: 4.74
Profitability:
  • EBIDTA: ($653,567.00)
  • Net Margins: -20.28%
  • Return on Equity: -24.80%
  • Return on Assets: -22.06%
Misc:
  • Average Volume: 15,021 shs.
  • Beta: 0.27
  • Short Ratio: 1.23
 
Frequently Asked Questions for Biomerica (OTCMKTS:BMRA)

What is Biomerica's stock symbol?

Biomerica trades on the OTCMKTS under the ticker symbol "BMRA."

How were Biomerica's earnings last quarter?

Biomerica, Inc. (OTCMKTS:BMRA) issued its quarterly earnings data on Tuesday, January, 17th. The company reported ($0.02) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The business had revenue of $1.43 million for the quarter, compared to the consensus estimate of $1.17 million. Biomerica had a negative return on equity of 24.80% and a negative net margin of 20.28%. View Biomerica's Earnings History.

When will Biomerica make its next earnings announcement?

Biomerica is scheduled to release their next quarterly earnings announcement on Monday, August, 28th 2017. View Earnings Estimates for Biomerica.

Who are some of Biomerica's key competitors?

Who are Biomerica's key executives?

Biomerica's management team includes the folowing people:

  • Zackary S. Irani, Chairman of the Board, Chief Executive Officer
  • Francis E. Capitanio, President
  • Janet Moore, Chief Financial Officer, Treasurer, Secretary, Director
  • Allen C. Barbieri, Independent Director
  • Francis R. Cano Ph.D., Independent Director
  • Jane F. Emerson M.D. Ph.D., Independent Director
  • Mark A. Sirgo Pharm.D., Independent Director

How do I buy Biomerica stock?

Shares of Biomerica can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biomerica's stock price today?

One share of Biomerica stock can currently be purchased for approximately $2.69.


MarketBeat Community Rating for Biomerica (OTCMKTS BMRA)
Community Ranking:  3.8 out of 5 (  )
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  13
MarketBeat's community ratings are surveys of what our community members think about Biomerica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Biomerica (OTCMKTS:BMRA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biomerica (OTCMKTS:BMRA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Biomerica (OTCMKTS:BMRA)
Earnings by Quarter for Biomerica (OTCMKTS:BMRA)
Earnings History by Quarter for Biomerica (OTCMKTS BMRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/28/2017N/AView Earnings Details
1/17/2017Q2 2017($0.03)($0.02)$1.17 million$1.43 millionViewN/AView Earnings Details
10/15/2015Q1 2016($0.02)($0.01)$1.32 million$1.29 millionViewN/AView Earnings Details
4/15/2015Q3 2015($0.01)($0.02)$1.50 million$1.30 millionViewN/AView Earnings Details
1/15/2015Q2 2015($0.01)($0.03)$1.40 million$1.13 millionViewN/AView Earnings Details
10/16/2014Q1 2015($0.03)($0.03)$1.24 million$1.03 millionViewN/AView Earnings Details
9/2/2014Q4 2014$0.02$0.02$1.43 million$1.68 millionViewN/AView Earnings Details
1/15/2014Nov 2013($0.01)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biomerica (OTCMKTS:BMRA)
Current Year EPS Consensus Estimate: $-0.0900 EPS
Next Year EPS Consensus Estimate: $-0.1700 EPS

Dividends

Dividend History for Biomerica (OTCMKTS:BMRA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Biomerica (OTCMKTS:BMRA)
Insider Trades by Quarter for Biomerica (OTCMKTS:BMRA)
Insider Trades by Quarter for Biomerica (OTCMKTS:BMRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2017Francis E CapitanioPresidentSell15,000$2.46$36,900.00View SEC Filing  
1/4/2017Janet MooreCFOSell4,500$2.20$9,900.00View SEC Filing  
12/22/2016Janet MooreCFOSell9,780$2.18$21,320.40View SEC Filing  
12/12/2016Francis E CapitanioPresidentSell9,351$2.77$25,902.27View SEC Filing  
12/8/2016Francis E CapitanioPresidentSell10,649$2.89$30,775.61View SEC Filing  
11/14/2016Zackary S IraniCEOBuy400$1.94$776.00View SEC Filing  
11/8/2016Zackary S IraniCEOBuy500$1.74$870.00View SEC Filing  
11/4/2016Zackary S IraniCEOBuy1,000$1.95$1,950.00View SEC Filing  
10/20/2016Francis E CapitanioPresidentSell10,000$2.68$26,800.00View SEC Filing  
10/3/2016Jane EmersonDirectorBuy1,000$2.80$2,800.00View SEC Filing  
9/7/2016Zackary S IraniCEOBuy199$2.65$527.35View SEC Filing  
8/12/2016Janet MooreCFOBuy2,200$2.98$6,556.00View SEC Filing  
8/12/2016Zackary S IraniInsiderBuy3,166$2.98$9,434.68View SEC Filing  
8/11/2016Zackary S IraniCEOBuy3,700$2.88$10,656.00View SEC Filing  
8/10/2016Zackary S IraniCEOBuy1,000$2.72$2,720.00View SEC Filing  
8/9/2016Allen BarbieriDirectorBuy3,000$2.54$7,620.00View SEC Filing  
8/5/2016Francis CanoDirectorBuy16,300$2.37$38,631.00View SEC Filing  
8/3/2016Mark A SirgoDirectorBuy4,000$2.05$8,200.00View SEC Filing  
8/3/2016Zackary S IraniCEOBuy2,609$2.10$5,478.90View SEC Filing  
8/2/2016Mark A SirgoDirectorBuy8,000$1.97$15,760.00View SEC Filing  
8/1/2016Zackary S IraniCEOBuy5,400$1.88$10,152.00View SEC Filing  
5/16/2016Francis E CapitanioPresidentSell20,000$1.50$30,000.00View SEC Filing  
11/13/2015Zackary S IraniCEOBuy5,000$0.83$4,150.00View SEC Filing  
6/8/2015Zackary S IraniCEOBuy3,000$1.08$3,240.00View SEC Filing  
5/22/2015Zackary S IraniCEOBuy2,000$0.85$1,700.00View SEC Filing  
5/11/2015Zackary S IraniCEOBuy18,000$0.91$16,380.00View SEC Filing  
9/6/2012Zackary S IraniCEOBuy7,000$0.70$4,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Biomerica (OTCMKTS:BMRA)
Latest Headlines for Biomerica (OTCMKTS:BMRA)
Source:
DateHeadline
finance.yahoo.com logoBiomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017
finance.yahoo.com - May 23 at 12:02 PM
finance.yahoo.com logoBMRA: Base Business Bouncing Back With Three Quarters of Sequential Growth
finance.yahoo.com - April 18 at 3:53 PM
finance.yahoo.com logoBiomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2017 By the Numbers : April 18, 2017
finance.yahoo.com - April 18 at 12:45 PM
finance.yahoo.com logoBiomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months
finance.yahoo.com - April 17 at 12:27 PM
finance.yahoo.com logoBiomerica to present at the 29th Annual ROTH conference on March 13, 2017
finance.yahoo.com - March 9 at 4:33 PM
finance.yahoo.com logoBMRA: Analysis of IBS Drugs Indicates Unmet Need for Alternative Therapies
finance.yahoo.com - January 26 at 4:39 PM
finance.yahoo.com logoBiomerica Announces Second Quarter Financial Results; Sales up Over 22% for the Quarter
finance.yahoo.com - January 18 at 3:23 PM
biz.yahoo.com logoBIOMERICA INC Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - January 17 at 4:43 PM
finance.yahoo.com logoBiomerica to Present at the 9th Annual LD Micro Main Event
finance.yahoo.com - November 30 at 10:33 AM
finance.yahoo.com logoBIOMERICA INC Financials
finance.yahoo.com - October 21 at 3:53 PM
finance.yahoo.com logoBMRA: Base Business Bounces Back, InFoods Continues To Attract Who’s-Who of IBS
finance.yahoo.com - October 20 at 3:24 PM
finance.yahoo.com logoBiomerica Announces First Quarter Fiscal 2017 Financial Results, Sales Increase Over Prior Year
finance.yahoo.com - October 18 at 8:44 AM
finance.yahoo.com logoBiomerica Highlights Recent Scientific Reports Indicating Increased Prevalence of IBS
finance.yahoo.com - October 4 at 8:39 AM
finance.yahoo.com logoBMRA: Progress of InFoods Prompts Upward Revision to Valuation
finance.yahoo.com - September 6 at 3:37 PM
finance.yahoo.com logoProgress of InFoods Prompts Upward Revision to Valuation
finance.yahoo.com - September 6 at 3:37 PM
feeds.benzinga.com logoExclusive: Newly-Listed Biomerica's CEO Talks IBS, Tech And Patient Care
feeds.benzinga.com - September 6 at 2:55 PM
finance.yahoo.com logoBiomerica to Present at 18th Annual Rodman & Renshaw Global Investment Conference
finance.yahoo.com - September 6 at 8:44 AM
rttnews.com logoHEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN
www.rttnews.com - August 25 at 8:46 AM
streetinsider.com logoBiomerica, Inc. (BMRA) Cleared to List on Nasdaq CM
www.streetinsider.com - August 24 at 3:52 PM
finance.yahoo.com logo8:20 am Biomerica common stock has been approved for listing on the Nasdaq Capital Market, expects to commence trading on Aug 26
finance.yahoo.com - August 24 at 12:08 PM
finance.yahoo.com logoBiomerica Updates Shareholders on Progress of Commercialization of Its New IBS Product
finance.yahoo.com - August 10 at 3:20 PM
finance.yahoo.com logoBMRA: More Positive Clarity on InFoods' FDA Pathway
finance.yahoo.com - July 13 at 10:20 AM
finance.yahoo.com logoFDA Determines That Biomerica's Proposed InFoods(R) IBS Clinical Investigation Is a Nonsignificant Risk (NSR) Device Study
finance.yahoo.com - July 11 at 7:47 AM
finance.yahoo.com logoBiomerica Signs Exclusive License Agreement for Korean Market With Total Value of up to $8.5 Million; Licensee Makes Equity Investment of $1m in Biomerica at $3 per Share
finance.yahoo.com - May 26 at 9:09 AM
biz.yahoo.com logoBIOMERICA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities
biz.yahoo.com - May 26 at 8:49 AM
finance.yahoo.com logoBiomerica Announces Third Quarter Financial Results, Sales up 10% for Nine Months
finance.yahoo.com - April 15 at 7:47 AM
finance.yahoo.com logoAll Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market
finance.yahoo.com - April 7 at 8:19 AM
biz.yahoo.com logoBIOMERICA INC Files SEC form 8-K, Other Events
biz.yahoo.com - March 16 at 6:07 AM
finance.yahoo.com logoBiomerica Announced That Its International Patent Application for IBS Was Reviewed by the ISA and All Claims Have Been Deemed Novel and Non-Obvious
finance.yahoo.com - March 14 at 8:19 AM
finance.yahoo.com logoBiomerica to Present at the ROTH Conference on March 16, 2016
finance.yahoo.com - March 10 at 8:49 AM
finance.yahoo.com logoBMRA: Q2 Results, IBS Advisory Board Beefed Up Further
finance.yahoo.com - January 19 at 12:00 PM
finance.yahoo.com logoBiomerica Announces Second Quarter Financial Results
finance.yahoo.com - January 15 at 8:19 AM

Social

Chart

Biomerica (BMRA) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by MarketBeat.com Staff